Hamburg Prostate Cancer Consortium

HPCC

Germany

About

The Hamburg Prostate Cancer Consortium (HPCC) represents a collaborative network dedicated to prostate cancer research between the University Medical Center Hamburg-Eppendorf (UKE) , the Martini-Klinik Prostate Cancer Center , the University of Hamburg (UH) , the Technical University of Hamburg (TUHH) as well as other institutes, clinics and research facilities within the greater city of Hamburg. Founded in 2022, the HPCC evolved from earlier collaborations including the “Forschungsgruppe Fortgeschrittenes Prostatakarzinom” (FFP) within the UKE network. The main objective of the HPCC is to create a common and recognized platform for scientific interaction between the partners to cultivate a synergistic integration of preclinical and translational expertise within the network. This is also depicted by the molecular structure of the network-label representing the medical knowledge as well as the closely connected equally ranked institutions shown as circles. The filled dot in the middle resembles the common meeting platform of the partners within the HPCC. Thus, the HPCC supports fast and direct translation of preclinical findings into clinical trials and patient care to ultimately advance interdisciplinary prostate cancer patient care. Thereby, the consortium works and interacts closely with local partners like the University Cancer Center Hamburg (UCCH) and international networks like the European Liquid Biopsy Society (ELBS) . The HPCC is also dedicated to inform the public on current areas of research within the network and would like to serve as a direct link to external collaborators, scientific researchers as well as patients. Several main areas of research are currently pursued with focus on tumor biology and progression as well as novel diagnostic possibilities (e.g. liquid biopsy based approaches) and therapeutical applications. A short comprehensive description on the HPCC and the different topics of research can be found here: https://www.uke.de/english/landingpage/hamburg-prostate-cancer-consortium-hpcc/index.html On behalf of the HPCC, Prof. Gunhild von Amsberg Prof. Wolfgang Maison PD. Dr. Wael Mansour Prof. Tobias Maurer Prof. Klaus Pantel Prof. Alexander Schlaefer Steering Board Coordination: Dr. Su Jung Oh-Hohenhorst, PhD

Experience

  • HPCC at HPCC
    Jan 2022 - Present · 4 yrs 6 mos

  • HPCC at University of Hamburg
    Jan 2022 - Present · 4 yrs 6 mos

  • HPCC at Universitätsklinikum Hamburg Eppendorf
    Jan 2022 - Present · 4 yrs 6 mos

  • HPCC at Martini-Klinik am UKE GmbH
    Jan 2022 - Present · 4 yrs 6 mos

  • HPCC at Hamburg University of Technology
    Jan 2022 - Present · 4 yrs 6 mos